Patents by Inventor Marat FUDIM

Marat FUDIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9398930
    Abstract: Methods and percutaneous devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via percutaneous carotid body ablation.
    Type: Grant
    Filed: June 3, 2013
    Date of Patent: July 26, 2016
    Assignee: CIBIEM, INC.
    Inventors: Mark Leung, Brett Schleicher, Charles Lennox, Ary Chernomorsky, Zoar Jacob Engelman, Marat Fudim, Martin M. Grasse, Mark Gelfand, Howard Levin
  • Patent number: 9393070
    Abstract: Systems, devices, and methods for treating a patient having a sympathetically mediated disease associated at least in part with augmented peripheral chemoreflex or heightened sympathetic activation. The treatments include ablating one or more peripheral chemoreceptors or associated afferent nerves to reduce or remove afferent neural signals from the peripheral chemoreceptor.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: July 19, 2016
    Assignee: CIBIEM, INC.
    Inventors: Mark Gelfand, Howard Levin, Charles Lennox, Marat Fudim, Zoar Jacob Engelman, Martin M. Grasse, Brett Schleicher
  • Publication number: 20140018788
    Abstract: Methods and endovascular catheters for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via transmural carotid body ablation.
    Type: Application
    Filed: July 5, 2013
    Publication date: January 16, 2014
    Inventors: Zoar Jacob Engelman, Martin M. Grasse, Mark Gelfand, Charles Lennox, Marwan Abboud, Mark Leung, Howard Levin, Marat Fudim, Michael Brick Markham, Miriam H. Taimisto, Kenneth M. Martin, Robert Brommer, Scott H. West
  • Publication number: 20130324989
    Abstract: Methods and percutaneous devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via percutaneous carotid body ablation.
    Type: Application
    Filed: June 3, 2013
    Publication date: December 5, 2013
    Inventors: Mark Leung, Brett Schleicher, Charles Lennox, Ary Chernomorsky, Zoar Jacob Engelman, Marat Fudim, Martin M. Grasse, Mark Gelfand, Howard Levin
  • Publication number: 20130324987
    Abstract: Methods and cryogenic devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via carotid body ablation.
    Type: Application
    Filed: June 3, 2013
    Publication date: December 5, 2013
    Inventors: Mark Leung, Eric Ryba, Charles Lennox, Ary Chernomorsky, Zoar Jacob Engelman, Marat Fudim, Martin M. Grasse, Mark Gelfand, Howard Levin, Brett Schleicher
  • Publication number: 20130310823
    Abstract: Systems, devices, and methods for treating a patient having a sympathetically mediated disease associated at least in part with augmented peripheral chemoreflex or heightened sympathetic activation. The treatments include ablating one or more peripheral chemoreceptors or associated afferent nerves to reduce or remove afferent neural signals from the peripheral chemoreceptor.
    Type: Application
    Filed: April 24, 2013
    Publication date: November 21, 2013
    Inventors: Mark Gelfand, Howard Levin, Charles Lennox, Marat Fudim, Zoar Jacob Engelman, Martin M. Grasse, Mark S. Leung, Brett Schleicher
  • Publication number: 20130303876
    Abstract: Planning for and/or assessment of an ablation procedure on one or both carotid bodies or carotid body chemoreceptors or carotid body nerves to treat patients having a sympathetically mediated cardiac, metabolic, and pulmonary disease (e.g. hypertension, CHF, diabetes, sleep disordered breathing) resulting from peripheral chemoreceptor hypersensitivity, carotid body hyperactivity, high carotid body afferent nerve signaling or heightened sympathetic activation.
    Type: Application
    Filed: March 28, 2013
    Publication date: November 14, 2013
    Inventors: Mark GELFAND, Howard LEVIN, Zoar Jacob ENGELMAN, Marat FUDIM